Active surveillance OK for non-muscle invasive bladder cancer
(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue of The Journal of Urology.
Feb 8, 2018
0
2